ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,837.07
0.06%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. OncoCyte Corporation (OCX)

  7. OncoCyte Corporation (OCX) Noticias

OCX

OncoCyte (OCX)

OncoCyte Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:OCX
FechaHoraFuenteTítuloSímboloCompañía
13/06/202315:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:OCXOncoCyte Corporation
09/06/202305:02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:OCXOncoCyte Corporation
19/05/202315:52Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:OCXOncoCyte Corporation
01/05/202315:49Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:OCXOncoCyte Corporation
18/04/202317:50Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:OCXOncoCyte Corporation
14/04/202315:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:OCXOncoCyte Corporation
12/04/202315:55Edgar (US Regulatory)Annual Report (10-k)AMEX:OCXOncoCyte Corporation
07/04/202309:39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:OCXOncoCyte Corporation
03/04/202305:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:OCXOncoCyte Corporation
14/02/202310:34Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:OCXOncoCyte Corporation
10/11/202215:50Edgar (US Regulatory)Quarterly Report (10-q)AMEX:OCXOncoCyte Corporation
22/09/202216:39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:OCXOncoCyte Corporation
26/05/202215:15Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:OCXOncoCyte Corporation
18/04/202208:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:OCXOncoCyte Corporation
29/07/202115:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:OCXOncoCyte Corporation
07/07/202115:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:OCXOncoCyte Corporation
15/06/202107:03Business WireEchelonDx & Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test Offeri...AMEX:OCXOncoCyte Corporation
09/06/202105:04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:OCXOncoCyte Corporation
01/06/202115:26Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:OCXOncoCyte Corporation
28/05/202116:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:OCXOncoCyte Corporation
21/05/202115:11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:OCXOncoCyte Corporation
08/03/202115:17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:OCXOncoCyte Corporation
05/03/202112:44Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:OCXOncoCyte Corporation
05/03/202107:01Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...AMEX:OCXOncoCyte Corporation
01/03/202115:34Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:OCXOncoCyte Corporation
05/02/202105:07Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)AMEX:OCXOncoCyte Corporation
18/05/202005:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:OCXOncoCyte Corporation
18/03/202014:15Edgar (US Regulatory)Unknown (sec Staff)AMEX:OCXOncoCyte Corporation
14/02/201907:00GlobeNewswire Inc.BioTime Provides Business Update Including Information on AgeX, OncoCyte and AsteriasAMEX:OCXOncoCyte Corporation
14/08/201815:10GlobeNewswire Inc.OncoCyte Reports Second Quarter 2018 Financial Results and Positive Corporate DevelopmentsAMEX:OCXOncoCyte Corporation
 Showing the most relevant articles for your search:AMEX:OCX

Su Consulta Reciente

USOTC
BASFY
BASF (QX)
FX
EURUSD
Euro vs US Dollar
NYSE
MRK
Merck
CCOM
OILBRENT
Brent Oil
AMEX
XLE
Energy Select Sector SPDR
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
FX
EURMXN
Euro vs MXN
AMEX
SPY
SPDR S&P 500
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
NYSE
CVX
Chevron
FX
USDMXN
US Dollar vs MXN
AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados